Post PARP inhibitor therapy-related acute megakaryoblastic leukemia in a patient with germline BRCA1 -mutated high-grade serous ovarian carcinoma.

Leukemia & lymphoma(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要